Showing 1 - 10 of 2,528
Technology Assessment (TA). This paper aims to characterize the equity on access of the Portuguese population in general, to a …
Persistent link: https://www.econbiz.de/10010907180
study are to present the results of a survey of HTA activities at the hospital level in Italy and to assess the relationship …
Persistent link: https://www.econbiz.de/10010875860
Cities in developed countries have increasingly adopted rainwater tanks as an alternative water source over the last 15 years. The rapid uptake of rainwater tanks has been driven by the need to reduce demand for centralised water services that are under pressure to adapt to population growth...
Persistent link: https://www.econbiz.de/10010998020
The paper focuses on the recent evolution in performance of healthcare production in Italy. It regards the technical … efficiency and equity in the use of public funds in public primary healthcare actions, concerning the funding profile in the new … Act. At article 32, health is recognized as a fundamental right of the individual and as a collective interest; equity and …
Persistent link: https://www.econbiz.de/10011157617
efficiency, equity, and administrative and compliance costs. This paper analyzes tax expenditures in Italy, considering the …
Persistent link: https://www.econbiz.de/10011123882
finance them, with a full breakdown per Regions. A useful work for stimulating the debate on health system reforms in Italy …
Persistent link: https://www.econbiz.de/10011110395
The College Voor Zorgverzekeringen (CVZ) provides guidance to the Dutch healthcare system on funding and use of new pharmaceutical technologies. This study examined the impact of evidence, process and context factors on CVZ decisions in 2004–2009. A data set of CVZ decisions pertaining to...
Persistent link: https://www.econbiz.de/10010993875
conditions, the absence of alternative treatment, and equity concerns should be also accounted for when assessing the “value for …
Persistent link: https://www.econbiz.de/10010993889
This paper describes and discusses the development and use of health technology assessment (HTA) in five Central and Eastern European countries (CEE): Poland, the Czech Republic, Hungary, Romania and Bulgaria. It provides a general snapshot of HTA policies in the selected CEE countries to date...
Persistent link: https://www.econbiz.de/10010993931
Without changes in the current policies, pharmaceutical companies will eventually cease responding to the incentives to develop orphan drugs, because they will increasingly be uncertain whether the drugs, if developed, will be reimbursed. </AbstractSection> Copyright Springer-Verlag Berlin Heidelberg 2014
Persistent link: https://www.econbiz.de/10010993990